SC 13G: Theriva Biologics, Inc.

AI Summary

SC 13G filing by Theriva Biologics, Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — ame of Issuer) Common stock, par value $0.001 per share (Title of Class of Securitie

Filing Documents

• ea0216645-13gintra_theriva.htm (SC 13G) — 63KB
• ea021664501ex99-1_theriva.htm (EX-99.1) — 3KB
• 0001213900-24-085044.txt ( ) — 68KB

If this statement is filed pursuant

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable. Item 4. Ownership. (a) and (b): (i) Immediately following the execution of the Securities Purchase Agreement with the Issuer on September 26, 2024 (the “ SPA ”) (as disclosed in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on September 30, 2024), each of the Reporting Persons may have been deemed to have beneficial ownership of 140,000 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA, and all such shares of Common Stock represent beneficial ownership of approximately 9.4% of the Common Stock, based on (1) 1,353,863 shares of Common Stock outstanding as of September 25, 2024, as reported by the Issuer, plus (2) 140,000 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA. The foregoing excludes 140,000 shares of Common Stock issuable upon exercise of a warrant to be issued to Intracoastal at the closing of the transaction contemplated by the SPA (the “ Intracoastal Warrant ”) because the Intracoastal Warrant contains a blocker provision under which the holder thereof does not have the right to exercise the Intracoastal Warrant to the extent (but only to the extent) that such exercise would result in beneficial the holder or any of the holder’s affiliates, of more than 4.99% of the Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership of 280,000 shares of Common Stock. Page 5 of 7 (ii) As of the close of business on October 3, 2024, each of the Reporting Persons may have been deemed to have beneficial ownership of 118,526 shares of Common Stock, whi

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. Page 6 of 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: October 3, 2024 /s/ Mitchell P. Kopin Mitchell P. Kopin /s/ Daniel B. Asher Daniel B. Asher Intracoastal Capital LLC By: /s/ Mitchell P. Kopin Mitchell P. Kopin, Manager Page 7 of 7

View Full Filing

View this SC 13G filing on SEC EDGAR